Worldwide

With fully integrated R&D and manufacturing operations across Canada, China and the USA, MIMA-PRO leads clinician focused and engineering driven novel applications in the Healthcare sector. MIMA-PRO plans to expand its global footprint by establishing a Japan-based Integrated Manufacturing facility that will provide efficacious treatments for Cancers and other life-threatening disease.

MIMA-Pro (Nan Tong) Scientific Inc.

Through its Nantong subsidiary MIMA-PRO was able to achieve significant Global Expansion with the major achievement of USA FDA approval:

MIMA-Pro (Nan Tong) is dedicated to the R&D and manufacturing of high-end energy-based surgical devices, minimally invasive oncology treatment systems, and advanced thermal therapy technologies. The company has been deeply engaged in the microwave medical field since the early 1990s, with over 30 years of accumulated expertise and is recognized as one of the original pioneers of microwave ablation technology.

Its flagship microwave ablation systems are widely used for the treatment of soft tissue ablation—including liver, lung, kidney, breast, and thyroid—and have been accepted and adopted in many world-renowned international clinical institutions. These systems support over 50,000 clinical procedures annually, contributing to MIMA-PRO’s position as a global market leader in microwave ablation.

Through MIMA-PRO’s Nantong operations the Company has obtained major medical device regulatory approvals across multiple regions, including:

• China NMPA Medical Device Registration
• United States FDA
• Japan PMDA
• India, Russia, Vietnam, and various other international markets

MIMA-Pro (Nan Tong) also collaborates closely with distinguished physicians and experts worldwide, supporting academic exchanges and contributing to high-impact scientific publications in journals such as Radiology and The Lancet. The company holds nearly 100 international patents, underpinning its strong technological leadership